{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:41:03Z","timestamp":1768254063363,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jocn.2024.04.011","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T17:32:17Z","timestamp":1713461537000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The rate of QMGS change predicts recurrence after thymectomy in myasthenia gravis"],"prefix":"10.1016","volume":"124","author":[{"given":"Xinxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2024.04.011_b0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2024.04.011_b0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized Trial of Thymectomy in Myasthenia Gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2024.04.011_b0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","article-title":"Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial","volume":"18","author":"Wolfe","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2024.04.011_b0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2024.04.011_b0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12967-021-03082-z","article-title":"Factors affecting improvement of neurologic status evaluated by Quantitative Myasthenia Gravis Score for patients with thymomatous myasthenia gravis after extended thymectomy","volume":"19","author":"Haoshuai","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.jocn.2024.04.011_b0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s42466-023-00252-w","article-title":"The impact of thymectomy in subgroups of Myasthenia gravis patients: a single center longitudinal observation","volume":"5","author":"Menghesha","year":"2023","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.jocn.2024.04.011_b0035","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/ene.15362","article-title":"Short-term and sustained clinical response following thymectomy in patients with myasthenia gravis","volume":"29","author":"Rath","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2024.04.011_b0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jns.2017.10.026","article-title":"Different neurologic outcomes of myasthenia gravis with thymic hyperplasia and thymoma after extended thymectomy: A single center experience","volume":"383","author":"Zheng","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2024.04.011_b0045","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/mus.26300","article-title":"Factors predicting remission in thymectomized patients with acetylcholine receptor antibody-positive myasthenia gravis","volume":"58","author":"Kim","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2024.04.011_b0050","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ene.14820","article-title":"Clinical characteristics and outcomes of thymoma-associated myasthenia gravis","volume":"28","author":"\u00c1lvarez-Velasco","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2024.04.011_b0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000478905","article-title":"Outcomes of Preoperative and Postoperative Corticosteroid Therapies in Myasthenia Gravis","volume":"78","author":"Jing","year":"2017","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2024.04.011_b0060","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/ene.14036","article-title":"Rapid improvement of muscle weakness post-thymectomy indicates good long-term neurological outcome in patients with ocular myasthenia gravis","volume":"26","author":"Geng","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2024.04.011_b0065","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1212\/01.WNL.0000163988.28892.79","article-title":"Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity","volume":"64","author":"Bedlack","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2024.04.011_b0070","doi-asserted-by":"crossref","unstructured":"Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci 1998;841:769\u201372. Doi: 10.1111\/j.1749-6632.1998.tb11015.x.","DOI":"10.1111\/j.1749-6632.1998.tb11015.x"},{"key":"10.1016\/j.jocn.2024.04.011_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/CND.0b013e31824619d5","article-title":"The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers","volume":"13","author":"Barnett","year":"2012","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.jocn.2024.04.011_b0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JND-150082","article-title":"Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale","volume":"2","author":"Barnett","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.jocn.2024.04.011_b0085","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2024.04.011_b0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2024.04.011_b0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2024.04.011_b0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/ane.12289","article-title":"Eight-year follow-up of patients with myasthenia gravis after thymectomy","volume":"131","author":"Yu","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2024.04.011_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102895","article-title":"Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications","volume":"132","author":"Chen","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jocn.2024.04.011_b0110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0188-4409(02)00405-8","article-title":"Thymectomy in Myasthenia Gravis: Response, Complications, and Associated Conditions","volume":"33","author":"Remes-Troche","year":"2002","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jocn.2024.04.011_b0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.17712\/nsj.2021.1.20190041","article-title":"Prevalence and risk factors of myasthenia gravis recurrence post-thymectomy","volume":"26","author":"Alqarni","year":"2021","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.jocn.2024.04.011_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0003-4975(01)02678-9","article-title":"Predictors of outcome in thymectomy for myasthenia gravis","volume":"72","author":"Budde","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jocn.2024.04.011_b0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/01616412.2018.1525121","article-title":"Clinical differences of early and late-onset myasthenia gravis in 985 patients","volume":"41","author":"Fan","year":"2019","journal-title":"Neurol Res"},{"key":"10.1016\/j.jocn.2024.04.011_b0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12016-016-8558-3","article-title":"Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review","volume":"52","author":"Truffault","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jocn.2024.04.011_b0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/ITT.S377056","article-title":"Novel Immunotherapies for Myasthenia Gravis","volume":"12","author":"Nair","year":"2023","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.jocn.2024.04.011_b0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.21037\/jtd.2017.12.07","article-title":"Independent long-term result of robotic thymectomy for myasthenia gravis, a single center experience","volume":"10","author":"Yin","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jocn.2024.04.011_b0145","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2147\/NDT.S243519","article-title":"Prognostic Analysis of Thymoma-Associated Myasthenia Gravis (MG) in Chinese Patients and Its Implication of MG Management: Experiences from a Tertiary Hospital","volume":"16","author":"Chen","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jocn.2024.04.011_b0150","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jocn.2024.04.011_b0155","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jocn.2024.04.011_b0160","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.nmd.2017.06.012","article-title":"Memory B cell resurgence requires repeated rituximab in myasthenia gravis","volume":"27","author":"Muto","year":"2017","journal-title":"Neuromuscul Disord"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824001498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824001498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T04:42:45Z","timestamp":1749357765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586824001498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S0967586824001498"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.04.011","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The rate of QMGS change predicts recurrence after thymectomy in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}